For biotech firms, a bit of positive news—a key result from clinical trials or new drug discovery, say—can be the difference between a major rally based on a path toward sustained profitability and a ...
- Company also reports a key milestone of Adjusted EBITDA 1 positive operations in Q3 2025 and expects to achieve strong additional profitability growth in Q1 and Q2 2026 through continued strong ...
One of the world’s largest biotech companies is closing its only office in the Bay Area. Pfizer is shutting down its office ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results